Nemera presents its pen injector’s offer to reach customers and patients’ needs
July 21, 2021Read moreThe latest issue of ‘EPR magazine’ is highlighting our experts discussion about developing Nemera’s pen-injector platform to reach customer needs
Nemera is happy to announce the launch of Novelia as Lunah by Cristalia on Brazilian market
July 20, 2021Read moreNemera’s preservative-free multi-dose eyedropper was launched by Cristalia in Brazilian Market
Nemera expands its insulin pen’s offer in Brazil
July 12, 2021Read moreNemera and Biomm sign partnership agreement to commercialize reusable insulin pen in Brazil
Going the extra mile to tackle dermal delivery challenges
July 1, 2021Read moreWe welcomed four experts for a round table in Paris to gather inputs and feedback on the role of dermal drug delivery devices in treatments administered to patients’ skin.
Nemera breaks ground in Brazil through Milfra acquisition
June 17, 2021Read moreNemera breaks ground in Brazil through Milfra acquisition With this acquisition Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America. Nemera today announced that they have entered into an agreement to acquire Milfra. Milfra, based in Jaguariuna, state of São Paulo, Brazil, specializes in the development
